Indications and uses
For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.
For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.
Carefully remove all cerumen and debris to allow hydrocortisone 1% and acetic acid 2% otic solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with the solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of the solution ever...
(Hydrocortisone and Acetic Acid Otic Solution, USP)
Rx only
Hydrocortisone and Acetic Acid Otic Solution, USP contains Hydrocortisone (1%) and acetic acid, glacial (2%) in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.2%), propylene glycol diacetate (3%) and sodium acetate (0.015%).
Acetic acid has a molecular formula of CH 3COOH with molecular weight of 60.05. The structural formula is:

Hydrocortisone is a Synthetic Steroid used as an anti-inflammatory and antipruritic agent. Its chemical name is Pregn-4-ene-3,20-dione, 11, 17, 21-trihydroxy-, (11β)-. Hydrocortisone has a molecular formula of C 21H 30O 5with molecular weight 362.46. The structural formula is:

Hydrocortisone and acetic acid is available as a non-aqueous otic solution buffered at pH (2.0 to 4.0) for use in the external ear canal.
Acetic acid is anti-bacterial and antifungal; hydrocortisone is anti-inflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.
For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.
Hypersensitivity to hydrocortisone and acetic acid otic solution or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.
Discontinue promptly if sensitization or irritation occurs.
Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.
Safety and effectiveness in pediatric patients below the age of 3 years have not been established.
Stinging or burning may be noted occasionally; local irritation has occurred very rarely.
Carefully remove all cerumen and debris to allow hydrocortisone 1% and acetic acid 2% otic solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with the solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of the solution every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.
Hydrocortisone 1% and acetic acid 2% otic solution is available in 10 mL plastic, controlled dropper tip bottle.
| 10 mL bottle | NDC 51672-3007-1 |
Store at 20° to 25°C (68° to 77°F)[see USP Controlled Room Temperature]. Protect from freezing. Keep container tightly closed.
Mfd. by: Taro Pharmaceuticals Inc.
Brampton, Ontario, Canada L6T 1C1
Dist. by:
Taro Pharmaceuticals U.S.A., Inc.
Hawthorne, NY 10532
Revised: May, 2015
PK-4785-1
61
0515-1
| Class | Version | Type | Effective |
|---|---|---|---|
| HYDROCORTISONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-3007-1 | Hydrocortisone and Acetic Acid | 10 mL in 1 BOTTLE | SOLUTION | 10 | 6 | |
| 51672-3007-1 | Hydrocortisone and Acetic Acid | 1 in 1 CARTON | SOLUTION | 1 | 6 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-3007-1 | ML - Milliliter | 51672-3007 | 7be2481b-4a85-4ea9-838e-507e807baaa6 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Acetic Acid | ACTIVE INGREDIENT | Q40Q9N063P | 2 | |
| Hydrocortisone | ACTIVE INGREDIENT | WI4X0X7BPJ | 2 | |
| Acetic Acid | ACTIVE MOIETY | Q40Q9N063P | 2 | |
| Hydrocortisone | ACTIVE MOIETY | WI4X0X7BPJ | 2 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | 2 | |
| benzethonium chloride | INACTIVE INGREDIENT | PH41D05744 | 2 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| propylene glycol diacetate | INACTIVE INGREDIENT | 5Z492UNF9O | 2 | |
| sodium acetate | INACTIVE INGREDIENT | 4550K0SC9B | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51672-3007 | 51672-3007-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM ACETATE | 4550K0SC9B | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLENE GLYCOL DIACETATE | 5Z492UNF9O | IACT |
| BENZETHONIUM CHLORIDE | PH41D05744 | IACT |
| HYDROCORTISONE | WI4X0X7BPJ | ACTIB |
| ACETIC ACID | Q40Q9N063P | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| benzethonium chloride | BENZETHONIUM CHLORIDE | PH41D05744 | SOLUTION / AURICULAR (OTIC) | 0.02 %w/v | ||
| propylene glycol diacetate | PROPYLENE GLYCOL DIACETATE | 5Z492UNF9O | SOLUTION / AURICULAR (OTIC) | 3 %w/v | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | ||
| sodium acetate | SODIUM ACETATE | 4550K0SC9B | SOLUTION / AURICULAR (OTIC) | 0.02 %w/v | ||
| sodium acetate | SODIUM ACETATE | 4550K0SC9B | SOLUTION / AURICULAR (OTIC) | 0.02 %w/v | ||
| benzethonium chloride | BENZETHONIUM CHLORIDE | PH41D05744 | SOLUTION / AURICULAR (OTIC) | 0.02 %w/v | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / RESPIRATORY (INHALATION) | 5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| propylene glycol diacetate | PROPYLENE GLYCOL DIACETATE | 5Z492UNF9O | SOLUTION / AURICULAR (OTIC) | 3 %w/v | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / RESPIRATORY (INHALATION) | 5 mg | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | 1 mg | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | 1 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A088759-001 | HYDROCORTISONE AND ACETIC ACID | ACETIC ACID, GLACIAL; HYDROCORTISONE | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 |
| Application-product | TE code |
|---|---|
| A088759-001 | AT |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | RLD, RS | 1985-03-04 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A088759-001 | HYDROCORTISONE AND ACETIC ACID | 2%;1% | SOLUTION/DROPS / OTIC | AT | 1985-03-04 | 3bdfa0b2c4d7… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A088759-001 | AT | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A088759-001 | AT | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A088759-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A088759-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A088759-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A088759-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A088759-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A088759-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A088759-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A088759-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A088759-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A088759-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A088759-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A088759-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A088759-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A088759-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A088759-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A088759-001 | AT | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A088759-001 | AT | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A088759-001 | AT | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A088759-001 | AT | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A088759-001 | AT | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A088759-001 | AT | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A088759-001 | AT | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A088759-001 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A088759-001 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A088759-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A088759-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A088759-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A088759-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A088759-001 | AT | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A088759-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A088759-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A088759-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A088759-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A088759-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A088759-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A088759-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A088759-001 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A088759-001 | AT | 1 | 3bdfa0b2c4d7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocortisone and Acetic Acid | HYDROCORTISONE AND ACETIC ACID | Sun Pharmaceutical Industries, Inc. | 6383c722-84e2-4719-a13d-19c54e3eefff | 2025-07-07 | Warnings, Adverse reactions | 51672-3007-1 51672-3007 51672300701 395a20ab-856b-3f08-e063-6294a90aa48e 6383c722-84e2-4719-a13d-19c54e3eefff |
Adverse event summaries are temporarily unavailable. Other product information remains available.